The largest database of trusted experimental protocols

Rabbit anti human c3c

Manufactured by Agilent Technologies
Sourced in Denmark

Rabbit anti human C3c is a laboratory reagent used for the detection and identification of the C3c component of the human complement system. It is a polyclonal antibody raised in rabbits against the C3c fragment of the human complement protein C3.

Automatically generated - may contain errors

3 protocols using rabbit anti human c3c

1

Mannan-based Complement C3 ELISA Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 306

Microtiter ELISA plate was coated with mannan from Saccharomyces cerevisiae (Sigma-Aldrich, M7504) for overnight at 4° C. in coating buffer [15 mM Na2CO3, 35 mM NaHCO3]. Plate was blocked with 1% bovine serum albumin (BSA) (Sigma-Aldrich, A3294) in Tris-buffered Saline (TBS) [10 mM Tris-HCl, 140 mM NaCl] for 2 hours at room temperature. 1% human serum was incubated with serial dilutions of small compounds in GVB++[4 mM Barbital, 145 mM NaCl, 0.2 mM MgCl2, 0.2 mM CaCl2), 1% Gelatin] and incubated for 15 minutes at room temperature. 100 μL of this mixture were then added to the plate and plate was incubated at 37° C. for up to an hour with gentle shaking, 200 rpm. After that, plate was washed thrice in wash buffer [TBS containing 5 mM CaCl2) and 0.05% Tween-20] and 100 μL of rabbit anti human C3c (Dako, A0062) diluted 1:5000 in wash buffer were added and incubated at 37° C. for 30 minutes. Plate was washed and 100 μL, of HRP goat anti rabbit IgG (Southern Biotech, 4050-05) diluted 1:8000 in wash buffer were added and incubated at room temperature for 30 minutes. After that, plate was washed three times and 100 μL/well of TMB Colorimetric substrate (Thermo Scientific, 34029) were added and incubated at room temperature for 5 minutes and the reaction was stop by adding 100 μL/well of 0.1 N sulfuric acid (BDH7230) and the absorbance was measured at 450 nm.

+ Open protocol
+ Expand
2

Purification and Labeling of Complement Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant proteins Efb, and Ecb, the leukocidin components Luk S37, and Luk S45, were expressed and purified as previously described [13 (link), 25 (link)]. The FH fragments FH1-4, FH5-7, and FH19-20 were expressed in Pichia pastoris [26 (link)–28 (link)] and FH and C3 were purified from plasma as described previously [15 (link)]. C3b was prepared from C3 using trypsin [29 (link)]. Soluble CR1 (sCR1) was obtained from CelldexTherapeutics (product code CDX-1135; Needham, MA), and human and bovine serum albumin (HSA and BSA, respectively) were purchased from Sigma-Aldrich (St. Louis, MO). Normal human serum (NHS) was obtained by pooling serum from at least five healthy consented laboratory workers and stored at -70°C until used (Ethical Committee decision 406/13/03/00/2015, Hospital district of Helsinki and Uusimaa). Labeling of sCR1 and C3b was performed with 125I (Perkin Elmer, Boston, MA) using the Pierce Iodination Reagent (Thermo Scientific, Rockford, IL) resulting in specific activity of 4.6–8.0 x 106 cpm/μg for sCR1 and 6.0–6.8 x 106 cpm/μg for C3b. The antibodies used were rabbit anti-human C3c (Dako, Denmark), Alexa Fluor® 488-labeled goat anti-rabbit (Invitrogen, Eugene, OR), and FITC-labeled goat anti-human C3 (Protos Immunoresearch, Burlingame, CA).
+ Open protocol
+ Expand
3

Complement Deposition Assay Using Modified IgG

Check if the same lab product or an alternative is used in the 5 most similar protocols
Maxisorp plates (Nunc) were randomly coated with 10 µg/ml (ca‐)IgG in coating buffer (0·1 M Na2CO3, 0·1 M NaHCO3, pH 9.6) In mixing experiments the final concentration was 10 µg/ml with different ratios between the ca‐IgG and non‐modified IgG, unless indicated otherwise. Plates were blocked with PBS/1% BSA and incubated with 1% normal human serum (NHS, pooled from four healthy donors) or heat‐inactivated NHS as a control (diluted in GVB++; 0·1% gelatin, 5 mM Veronal, 145 mM NaCl, 0·025% NaN3, 0·15 mM CaCl2, 0·5 mM MgCl2, pH 7.3). Complement binding or deposition was analyzed with rabbit anti‐human C1q (Dako; cat. no. A0136), goat anti‐human C4 (Quidel, San Diego, CA, USA; cat. no. A305), rabbit anti‐human C3c (Dako; cat. no. A0062) and mouse anti‐human C5b9 (Dako; cat. no. M0777) with corresponding HRP‐labelled secondary antibodies in PBS/1% BSA/0·05% Tween. Finally, the substrate was added using ABTS and absorbance measured at 415 nm using the Biorad iMark Microplate Absorbance Reader.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!